Poolman Jan T, Torres Victor J, Missiakas Dominique, Welten Suzanne P M, Fernandez Jeffrey, DuMont Ashley L, O'Keeffe Anna, Konstantinov Sergey R, Morrow Brian, Burghout Peter, Grijpstra Jan, van Beers Miranda M C, Anish Chakkumkal, Beurret Michel, Geurtsen Jeroen, Rood Pauline M L, Koeberling Oliver, Shi Miaomiao, van den Dobbelsteen Germie P J M
Bacterial Vaccines Discovery and Early Development, Janssen Vaccines and Prevention B.V Archimedesweg 4-6, Leiden, The Netherlands.
Department of Microbiology, New York University School of Medicine, Alexandria Center for Life Science, New York, NY, USA.
NPJ Vaccines. 2025 Apr 20;10(1):78. doi: 10.1038/s41541-025-01119-8.
Staphylococcus aureus is a major cause of bacterial infection-related deaths. Increasing antimicrobial resistance highlights the urgent need for effective preventative strategies. Antibody-mediated opsonophagocytosis, the key mechanism for protection against S. aureus, is disabled by critical virulence factors such as Staphylococcal protein A (SpA) and leukocidin AB (LukAB). In our study, we combined genetically detoxified vaccine candidates SpA* and LukAB RARPR-33 with a T1 adjuvant aiming to restore host antibody functionality. To evaluate these vaccine candidates, we developed both surgical site infection (SSI) and superficial wound infection (SWI) models in minipigs. Our results showed a significant reduction in bacterial load and systemic dissemination in the SSI model, while skin infection severity was markedly decreased after intradermal immunization in the SWI model. This study introduces a novel S. aureus vaccine strategy by targeting immune evasion factors SpA and LukAB, utilizing potent T1 adjuvants, and employing minipig challenge models.
Cochrane Database Syst Rev. 2017-5-18
Health Technol Assess. 2024-7
Cochrane Database Syst Rev. 2024-12-2
Cochrane Database Syst Rev. 2013-8-19
Nat Rev Microbiol. 2025-8-20
Front Cell Infect Microbiol. 2023-9-27
Nat Rev Immunol. 2023-10
Nat Rev Microbiol. 2023-6
Front Cell Infect Microbiol. 2022
Vaccine. 2021-6-29